164 related articles for article (PubMed ID: 34944790)
21. Epidermal growth factor promotes glioblastoma cell death under glucose deprivation via upregulation of xCT (SLC7A11).
Yamamoto M; Teramoto K; Katoh H
Cell Signal; 2021 Feb; 78():109874. PubMed ID: 33285240
[TBL] [Abstract][Full Text] [Related]
22. The role of system Xc
Dang DK; Shin EJ; Tran HQ; Kim DJ; Jeong JH; Jang CG; Nah SY; Sato H; Nabeshima T; Yoneda Y; Kim HC
Neurochem Int; 2017 Sep; 108():254-265. PubMed ID: 28457879
[TBL] [Abstract][Full Text] [Related]
23. Immunotherapy against the Cystine/Glutamate Antiporter xCT Improves the Efficacy of APR-246 in Preclinical Breast Cancer Models.
Barutello G; Di Lorenzo A; Gasparetto A; Galiazzi C; Bolli E; Conti L; Cavallo F
Biomedicines; 2022 Nov; 10(11):. PubMed ID: 36359363
[TBL] [Abstract][Full Text] [Related]
24. The glutamate/cystine antiporter SLC7A11/xCT enhances cancer cell dependency on glucose by exporting glutamate.
Koppula P; Zhang Y; Shi J; Li W; Gan B
J Biol Chem; 2017 Aug; 292(34):14240-14249. PubMed ID: 28630042
[TBL] [Abstract][Full Text] [Related]
25. Comparative analysis of antibodies to xCT (Slc7a11): Forewarned is forearmed.
Van Liefferinge J; Bentea E; Demuyser T; Albertini G; Follin-Arbelet V; Holmseth S; Merckx E; Sato H; Aerts JL; Smolders I; Arckens L; Danbolt NC; Massie A
J Comp Neurol; 2016 Apr; 524(5):1015-32. PubMed ID: 26494316
[TBL] [Abstract][Full Text] [Related]
26. Temozolomide toxicity operates in a xCT/SLC7a11 dependent manner and is fostered by ferroptosis.
Sehm T; Rauh M; Wiendieck K; Buchfelder M; Eyüpoglu IY; Savaskan NE
Oncotarget; 2016 Nov; 7(46):74630-74647. PubMed ID: 27612422
[TBL] [Abstract][Full Text] [Related]
27. Identification and characterisation of human xCT that co-expresses, with 4F2 heavy chain, the amino acid transport activity system xc-.
Bassi MT; Gasol E; Manzoni M; Pineda M; Riboni M; Martín R; Zorzano A; Borsani G; Palacín M
Pflugers Arch; 2001 May; 442(2):286-96. PubMed ID: 11417227
[TBL] [Abstract][Full Text] [Related]
28. Combination therapy in a xenograft model of glioblastoma: enhancement of the antitumor activity of temozolomide by an MDM2 antagonist.
Wang H; Cai S; Bailey BJ; Reza Saadatzadeh M; Ding J; Tonsing-Carter E; Georgiadis TM; Zachary Gunter T; Long EC; Minto RE; Gordon KR; Sen SE; Cai W; Eitel JA; Waning DL; Bringman LR; Wells CD; Murray ME; Sarkaria JN; Gelbert LM; Jones DR; Cohen-Gadol AA; Mayo LD; Shannon HE; Pollok KE
J Neurosurg; 2017 Feb; 126(2):446-459. PubMed ID: 27177180
[TBL] [Abstract][Full Text] [Related]
29. Interleukin 1β Regulation of the System xc- Substrate-specific Subunit, xCT, in Primary Mouse Astrocytes Involves the RNA-binding Protein HuR.
Shi J; He Y; Hewett SJ; Hewett JA
J Biol Chem; 2016 Jan; 291(4):1643-1651. PubMed ID: 26601945
[TBL] [Abstract][Full Text] [Related]
30. System xC- is a mediator of microglial function and its deletion slows symptoms in amyotrophic lateral sclerosis mice.
Mesci P; Zaïdi S; Lobsiger CS; Millecamps S; Escartin C; Seilhean D; Sato H; Mallat M; Boillée S
Brain; 2015 Jan; 138(Pt 1):53-68. PubMed ID: 25384799
[TBL] [Abstract][Full Text] [Related]
31. Sex- and age-dependent contribution of System x
Frare C; Pitt SK; Hewett SJ
Front Behav Neurosci; 2023; 17():1238349. PubMed ID: 37649973
[TBL] [Abstract][Full Text] [Related]
32. Analysis of the effects of polyunsaturated fatty acids on transporter expressions using a PCR array: Induction of xCT/SLC7A11 in human placental BeWo cells.
Ono K; Furugen A; Kurosawa Y; Jinno N; Narumi K; Kobayashi M; Iseki K
Placenta; 2019 Jan; 75():34-41. PubMed ID: 30712664
[TBL] [Abstract][Full Text] [Related]
33. Detection of p53 mutations in proliferating vascular cells in glioblastoma multiforme.
Kawasoe T; Takeshima H; Yamashita S; Mizuguchi S; Fukushima T; Yokogami K; Yamasaki K
J Neurosurg; 2015 Feb; 122(2):317-23. PubMed ID: 25415071
[TBL] [Abstract][Full Text] [Related]
34. Overexpression of Cystine/Glutamate Antiporter xCT Correlates with Nutrient Flexibility and ZEB1 Expression in Highly Clonogenic Glioblastoma Stem-like Cells (GSCs).
Koch K; Hartmann R; Suwala AK; Rios DH; Kamp MA; Sabel M; Steiger HJ; Willbold D; Sharma A; Kahlert UD; Maciaczyk J
Cancers (Basel); 2021 Nov; 13(23):. PubMed ID: 34885110
[TBL] [Abstract][Full Text] [Related]
35. Expression of xCT and activity of system xc(-) are regulated by NRF2 in human breast cancer cells in response to oxidative stress.
Habib E; Linher-Melville K; Lin HX; Singh G
Redox Biol; 2015 Aug; 5():33-42. PubMed ID: 25827424
[TBL] [Abstract][Full Text] [Related]
36. Over-expressed lncRNA HOTAIRM1 promotes tumor growth and invasion through up-regulating HOXA1 and sequestering G9a/EZH2/Dnmts away from the HOXA1 gene in glioblastoma multiforme.
Li Q; Dong C; Cui J; Wang Y; Hong X
J Exp Clin Cancer Res; 2018 Oct; 37(1):265. PubMed ID: 30376874
[TBL] [Abstract][Full Text] [Related]
37. Human glioblastoma multiforme: p53 reactivation by a novel MDM2 inhibitor.
Costa B; Bendinelli S; Gabelloni P; Da Pozzo E; Daniele S; Scatena F; Vanacore R; Campiglia P; Bertamino A; Gomez-Monterrey I; Sorriento D; Del Giudice C; Iaccarino G; Novellino E; Martini C
PLoS One; 2013; 8(8):e72281. PubMed ID: 23977270
[TBL] [Abstract][Full Text] [Related]
38. Inhibiting the system x
Liu DS; Duong CP; Haupt S; Montgomery KG; House CM; Azar WJ; Pearson HB; Fisher OM; Read M; Guerra GR; Haupt Y; Cullinane C; Wiman KG; Abrahmsen L; Phillips WA; Clemons NJ
Nat Commun; 2017 Mar; 8():14844. PubMed ID: 28348409
[TBL] [Abstract][Full Text] [Related]
39. An accelerated senescence response to radiation in wild-type p53 glioblastoma multiforme cells.
Quick QA; Gewirtz DA
J Neurosurg; 2006 Jul; 105(1):111-8. PubMed ID: 16871885
[TBL] [Abstract][Full Text] [Related]
40. HIF1α and p53 Regulated MED30, a Mediator Complex Subunit, is Involved in Regulation of Glioblastoma Pathogenesis and Temozolomide Resistance.
Shukla A; Srivastava S; Darokar J; Kulshreshtha R
Cell Mol Neurobiol; 2021 Oct; 41(7):1521-1535. PubMed ID: 32705436
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
